Central neck lymph node dissection for papillary thyroid cancer: comparison of complication and recurrence rates in 295 initial dissections and reoperations
- PMID: 20231628
- DOI: 10.1001/archsurg.2010.9
Central neck lymph node dissection for papillary thyroid cancer: comparison of complication and recurrence rates in 295 initial dissections and reoperations
Abstract
Background: The American Thyroid Association recently changed its management guidelines for papillary thyroid cancer (PTC) to include routine central neck lymph node dissection (CLND) during thyroidectomy. We currently perform CLND during thyroidectomy only if enlarged central nodes are detected by palpation or ultrasonography; we perform CLND in the reoperative setting for recurrence in previously normal-appearing or incompletely resected nodes. Critics of this approach argue that reoperative CLND has higher complication and recurrence rates than initial CLND. We sought to test this argument, using it as our hypothesis.
Design: Retrospective review.
Setting: University hospital.
Patients: All patients undergoing CLND for PTC between January 1, 1998, and December 31, 2007.
Interventions: Thyroidectomy and CLND.
Main outcome measures: Complications (neck hematoma, recurrent laryngeal nerve injury, and hypoparathyroidism) and recurrence of PTC.
Results: Altogether, 295 CLNDs were performed: 189 were initial operations and 106 were reoperations. The rate of transient hypocalcemia (41.8% vs 23.6%) was significantly higher in patients undergoing initial CLND compared with those undergoing reoperative CLND. Rates of neck hematoma (1.1% vs 0.9%), transient hoarseness (4.8% vs 4.7%), permanent hoarseness (2.6% vs 1.9%), and permanent hypoparathyroidism (0.5% vs 0.9%) were not different between initial and reoperative CLND. In addition, recurrence rates in the central (11.6% vs 14.1%) and lateral (21.7% vs 17.0%) compartments were not different between the 2 groups.
Conclusions: Reoperative CLND for PTC has a lower rate of temporary hypocalcemia, the same rate of other complications, and the same rate of recurrence compared with initial CLND. Choosing to observe nonenlarged central neck lymph nodes for PTC does not result in increased complications or recurrence if reoperation is required.
Comment in
-
Failure to consider the number of dissected sides can bias complication rate calculations of central lymph node dissection for thyroid cancer.Arch Surg. 2010 Oct;145(10):1026-7; author reply 1027. doi: 10.1001/archsurg.2010.202. Arch Surg. 2010. PMID: 20956780 No abstract available.
Similar articles
-
Central lymph node dissection as a secondary procedure for papillary thyroid cancer: Is there added morbidity?Surgery. 2009 May;145(5):514-8. doi: 10.1016/j.surg.2009.01.013. Epub 2009 Mar 27. Surgery. 2009. PMID: 19375610
-
Routine bilateral central lymph node clearance for papillary thyroid cancer.Surgery. 2009 Oct;146(4):696-703; discussion 703-5. doi: 10.1016/j.surg.2009.06.046. Surgery. 2009. PMID: 19789029
-
Reoperative central lymph node dissection for incidental papillary thyroid cancer can be performed safely: A retrospective review.Int J Surg. 2018 Aug;56:102-107. doi: 10.1016/j.ijsu.2018.06.015. Epub 2018 Jun 18. Int J Surg. 2018. PMID: 29920338
-
Peroperative diagnosis and treatment of metastases to the regional lymph nodes in papillary carcinoma of the thyroid gland.Surg Gynecol Obstet. 1989 Aug;169(2):107-14. Surg Gynecol Obstet. 1989. PMID: 2667172 Review.
-
Level VI lymph node dissection for papillary thyroid cancer.Minerva Chir. 2007 Oct;62(5):383-93. Minerva Chir. 2007. PMID: 17947949
Cited by
-
Central compartment revision surgery for persistent or recurrent thyroid carcinoma: analysis of survival and complication rate.Eur Arch Otorhinolaryngol. 2019 Feb;276(2):551-557. doi: 10.1007/s00405-018-5239-2. Epub 2018 Dec 10. Eur Arch Otorhinolaryngol. 2019. PMID: 30535975
-
Identifying risk factors of recurrence for clinically node negative papillary thyroid carcinoma with pathologic N1a.BMC Surg. 2019 Jul 5;19(1):78. doi: 10.1186/s12893-019-0541-5. BMC Surg. 2019. PMID: 31277631 Free PMC article.
-
Effect of prophylactic central neck dissection on the surgical outcomes in papillary thyroid cancer: experience in a single center.Eur Arch Otorhinolaryngol. 2020 May;277(5):1491-1497. doi: 10.1007/s00405-020-05830-1. Epub 2020 Feb 12. Eur Arch Otorhinolaryngol. 2020. PMID: 32052141
-
A Randomized Controlled Clinical Trial: No Clear Benefit to Prophylactic Central Neck Dissection in Patients With Clinically Node Negative Papillary Thyroid Cancer.Ann Surg. 2020 Sep 1;272(3):496-503. doi: 10.1097/SLA.0000000000004345. Ann Surg. 2020. PMID: 33759836 Free PMC article. Clinical Trial.
-
Differentiated thyroid cancer: indications and extent of central neck dissection--our experience.Int J Surg Oncol. 2013;2013:625193. doi: 10.1155/2013/625193. Epub 2013 Sep 26. Int J Surg Oncol. 2013. PMID: 24282633 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical